Calls
03/11/2021
Preannouncement: Transnational Call for Proposals - Era Permed (Prevention in Personalised Medicine)
03/11/2021
17/02/2022
Instituto de Salud Carlos III, Asociación Española Contra el Cáncer. Participación del Gobierno de Navarra
Projects
International
03/11/2021
Añadir al calendario
2021-11-03 01:00:00
2022-02-17 01:00:00
Preannouncement: Transnational Call for Proposals - Era Permed (Prevention in Personalised Medicine)
Through its fifth transnational call, ERA PerMed aims to foster research on prevention in personalised medicine. The overarching goal of the call is the development of tailor-made strategies for prevention of disease and disease progression, at three different levels:
Preventive measures decreasing the rate of incidence (primary prevention)
Early detection to increase the efficacy of a preventive therapy, even before symptoms are developed (secondary prevention)
Interventions preventing disease recurrence or improving patients’ care and quality of life (tertiary prevention).
Research on prevention from over-treatment or overmedicalisation in primary, secondary and tertiary personalised preventive approaches is optional and could be part of research proposals, if applicable. The clinical relevance of the proposed PM approach needs to be convincingly demonstrated.
The call is planned to be launched on December 1st, 2021, with a submission deadline for preproposals on February 17, 2022.
More information about the Pre Announcement
Location
Navarrabiomed
info@navarrabiomed
Europe/Madrid
public
Through its fifth transnational call, ERA PerMed aims to foster research on prevention in personalised medicine. The overarching goal of the call is the development of tailor-made strategies for prevention of disease and disease progression, at three different levels:
- Preventive measures decreasing the rate of incidence (primary prevention)
- Early detection to increase the efficacy of a preventive therapy, even before symptoms are developed (secondary prevention)
- Interventions preventing disease recurrence or improving patients’ care and quality of life (tertiary prevention).
Research on prevention from over-treatment or overmedicalisation in primary, secondary and tertiary personalised preventive approaches is optional and could be part of research proposals, if applicable. The clinical relevance of the proposed PM approach needs to be convincingly demonstrated.
The call is planned to be launched on December 1st, 2021, with a submission deadline for preproposals on February 17, 2022.